283 related articles for article (PubMed ID: 18446409)
1. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm.
Mayer TE; Dichgans M; Straube A; Birnbaum T; Müller-Schunk S; Hamann GF; Schulte-Altedorneburg G
Cardiovasc Intervent Radiol; 2008; 31(6):1200-4. PubMed ID: 18446409
[TBL] [Abstract][Full Text] [Related]
2. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
Duman E; Karakoç F; Pinar HU; Dogan R; Fırat A; Yıldırım E
Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512
[TBL] [Abstract][Full Text] [Related]
3. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
[TBL] [Abstract][Full Text] [Related]
4. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
[TBL] [Abstract][Full Text] [Related]
5. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
[TBL] [Abstract][Full Text] [Related]
6. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N
Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
[TBL] [Abstract][Full Text] [Related]
7. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Danz S; Ernemann U; Schuhmann MU
World Neurosurg; 2016 Apr; 88():104-112. PubMed ID: 26732964
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Hänggi D; Beseoglu K; Turowski B; Steiger HJ
Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
[TBL] [Abstract][Full Text] [Related]
9. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
10. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Aburto-Murrieta Y; Marquez-Romero JM; Bonifacio-Delgadillo D; López I; Hernández-Curiel B
Vasc Endovascular Surg; 2012 Aug; 46(6):460-5. PubMed ID: 22914892
[TBL] [Abstract][Full Text] [Related]
11. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
Anand S; Goel G; Gupta V
J Neurosurg Anesthesiol; 2014 Jan; 26(1):92-3. PubMed ID: 23774116
[No Abstract] [Full Text] [Related]
12. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.
Hänggi D; Turowski B; Beseoglu K; Yong M; Steiger HJ
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1053-60. PubMed ID: 18372422
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage.
Hui C; Lau KP
Clin Radiol; 2005 Sep; 60(9):1030-6. PubMed ID: 16124986
[TBL] [Abstract][Full Text] [Related]
14. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
[TBL] [Abstract][Full Text] [Related]
15. Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage.
Hejčl A; Cihlář F; Smolka V; Vachata P; Bartoš R; Procházka J; Cihlář J; Sameš M
Acta Neurochir (Wien); 2017 Apr; 159(4):713-720. PubMed ID: 28224318
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.
Conti A; Angileri FF; Longo M; Pitrone A; Granata F; La Rosa G
Acta Neurochir (Wien); 2008 Nov; 150(11):1197-202; discussion 1202. PubMed ID: 18958388
[TBL] [Abstract][Full Text] [Related]
17. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S
Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268
[TBL] [Abstract][Full Text] [Related]
18. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study.
Dehdashti AR; Binaghi S; Uske A; Regli L
Neurol India; 2011; 59(6):810-6. PubMed ID: 22234190
[TBL] [Abstract][Full Text] [Related]
19. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.
Doukas A; Petridis AK; Barth H; Jansen O; Maslehaty H; Mehdorn HM
Acta Neurochir Suppl; 2011; 112():93-6. PubMed ID: 21691994
[TBL] [Abstract][Full Text] [Related]
20. Aggressive management of vasospasm with direct intra-arterial nimodipine therapy.
Narayan V; Pendharkar H; Devi BI; Bhat DI; Shukla DP
Neurol India; 2018; 66(2):416-422. PubMed ID: 29547164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
